Form 4: Akamai CTO Sells 3,500 Shares Under 10b5-1 Plan

Akamai Technologies' Chief Technology Officer, Robert Blumofe, sold 3,500 shares of common stock for $86 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Robert Blumofe, Chief Technology Officer of Akamai Technologies Inc. (AKAM), reported a sale of company common stock.
• The transaction involved the disposition of 3,500 shares.
• The shares were sold at a price of $86 per share.
• The sale was executed on November 7, 2025.
• This transaction was conducted pursuant to a Rule 10b5-1 trading plan, which was adopted by Dr. Blumofe on March 12, 2025.
• Following this transaction, Dr. Blumofe directly beneficially owns 24,410 shares of common stock.
• Additionally, Dr. Blumofe indirectly beneficially owns 64.184 shares through a 401(k) Plan as of November 6, 2025.

Sentiment

Score: 5

Explanation: Neutral. A routine insider sale under a pre-arranged 10b5-1 plan, which is a common practice for executives to manage their equity holdings without implying a specific sentiment about the company's future performance.

Future Outlook

No specific future outlook or guidance is provided in this insider transaction disclosure.

Industry Context

This is a routine insider transaction disclosure, reflecting an individual executive's pre-planned portfolio management rather than broader industry trends or company-specific strategic shifts.

Related Party Transactions

• Robert Blumofe, Chief Technology Officer, sold 3,500 shares of Akamai Technologies common stock.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but executed under a pre-arranged 10b5-1 plan, which typically mitigates concerns about negative signaling.

Key Dates

Recommendation

The filing details a routine insider stock sale by the Chief Technology Officer under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and personal financial planning and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation based solely on this disclosure. Therefore, a 'hold' recommendation is appropriate as this filing provides no new material information to alter an existing investment thesis.

Keywords

Akamai Technologies, AKAM, Robert Blumofe, CTO, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, Beneficial Ownership